Published 2 days ago • loading... • Updated 2 days agoShow Less IconWhy metformin matters beyond diabetes: New target could reshape aging and cancer research Summary by Medical XpressScientists at Université de Montréal have figured out how metformin—a common drug that's used to treat type-2 diabetes and that may cut the risk of developing cancer and even help humans and other mammals live longer—actually works.Share menu1 Articles1 ArticlesAllLeftCenter1RightSearch IconSort IconMedical XpressCenterFactualityOwnershipWhy metformin matters beyond diabetes: New target could reshape aging and cancer researchScientists at Université de Montréal have figured out how metformin—a common drug that's used to treat type-2 diabetes and that may cut the risk of developing cancer and even help humans and other mammals live longer—actually works.2 days agoRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right0Center1Last Updated2 days agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageMedical Xpress broke the news 2 days ago on Friday, May 29, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsDiabetes Plus IconMedical Plus IconCancer Plus IconMammals Plus IconMontreal Plus IconNature & Animals Plus IconHealth & Medicine Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsDiabetes Plus IconMedical Plus IconCancer Plus IconMammals Plus IconMontreal Plus IconNature & Animals Plus IconHealth & Medicine Plus IconShow All